References

Citations

1. Guintoli RL II, Bristow RE (2008). Cervical cancer. In RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 971–988. Philadelphia: Lippincott Williams and Wilkins.

2. Cannistra SA (2007). Gynecologic cancer. In DC Dale, DD Federman, eds., ACP Medicine, section 12, chap. 10. New York: WebMD.

3. Eifel PJ, et al. (2004). Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. Journal of Clinical Oncology, 22(5): 872–880.

4. Trimble CL, et al. (2005). Active and passive cigarette smoking and the risk of cervical neoplasia. Obstetrics and Gynecology, 105(1): 174–181.

5. Moreno V, et al. (2002). Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC muticentric case-control study. Lancet, 359(9312): 1085–1092.

6. Chirenje ZM (2005). HIV and cancer of the cervix. Best Practice and Research Clinical Obstetrics and Gynaecology, 19(2): 269–276.

7. Waggoner SE (2003). Cervical cancer. Lancet, 361: 2217–2225.

8. Thigpen T (2003). The role of chemotherapy in the management of carcinoma of the cervix. Cancer Journal, 9(5): 425–432.

9. Sundar S, et al. (2008). Cervical cancer, search date November 2006. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.

10. Janicek MF, Averette HE. (2001). Cervical cancer: Prevention, diagnosis, and therapeutics. CA, A Cancer Journal for Clinicians, 51: 92–114.

11. Holschneider CH (2007). Premalignant and malignant disorders of the uterine cervix. In AH DeCherney et al., eds., Current Diagnosis and Treatment Obstetrics and Gynecology, 10th ed., pp. 833–854. New York: McGraw-Hill Medical Publishing Division.

12. American College of Obstetricians and Gynecologists (2002, reaffirmed 2006). Diagnosis and treatment of cervical carcinomas. ACOG Practice Bulletin No. 35. Obstetrics and Gynecology, 99(5): 855–867.

13. National Cancer Institute (2008). Cervical Cancer (PDQ): Prevention—Health Professional Version. Available online: http://www.nci.nih.gov/cancertopics/pdq/prevention/cervical/healthprofessional.

14. U.S. Food and Drug Administration (2006). FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html.

15. Winer RL, et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. New England Journal of Medicine, 354(25): 2645–2654.

16. Lertsanguansinchai P, et al. (2004). Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. International Journal of Radiation Oncology Biology Physics, 59(5): 1424–1431.

17. Baxter NN, et al. (2005). Risk of pelvic fractures in older women following pelvic irradiation. JAMA, 294(20): 2587–2593.

Other Works Consulted

• American Cancer Society (2007). Cancer Facts and Figures for African Americans 2007–2008. Atlanta: American Cancer Society. Available online: http://www.cancer.org/downloads/STT/CAFF2007AAacspdf2007.pdf.

• Eifel PJ, et al. (2008). Cancer of the cervix, vagina, and vulva. In VT DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 8th ed., vol. 1, pp. 1496–1540. Philadelphia: Lippincott Williams and Wilkins.

• Kaferle JE, Malouin JM (2001). Evaluation and management of the AGUS Papanicolaou smear. American Family Physician, 63(11): 2239–2244.

• Sawaya GF, et al. (2000). Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstetrics and Gynecology, 96(2): 219–223.